Reduced-intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed non-Hodgkin and Hodgkin's lymphomas

被引：0
作者：
Corradini, P
Dodero, A
Bregni, M
Olivieri, A
Valagussa, P
Farina, L
Milani, R
Scime, R
Rambaldi, A
Bonifazi, F
Patriarca, F
Locasciulli, A
Bacigalupo, A
Gianni, A
Tarella, C
机构：
[1] Ist Nazl Tumori, I-20133 Milan, Italy
[2] Ist San Raffaele, Milan, Italy
[3] Univ Ancona, Ancona, Italy
[4] Opsed Cervello, Palermo, Italy
[5] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[6] Osped St Orsola, Bologna, Italy
[7] Univ Udine, I-33100 Udine, Italy
[8] Osped San Camillo, Rome, Italy
[9] Osped San Martino Genova, Genoa, Italy
[10] Univ Turin, Turin, Italy
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
[21]   Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [J].
Nath, Karthik ;
Peterson, Kristen ;
Brown, Samantha ;
Devlin, Sean ;
Rodriguez, Natasia ;
Barker, Juliet ;
Giralt, Sergio ;
Gyurkocza, Boglarka ;
Jakubowski, Ann ;
Papadopoulos, Esperanza ;
Ponce, Doris ;
Scordo, Michael ;
Shah, Gunjan ;
Perales, Miguel-Angel ;
Sauter, Craig ;
Lin, Andrew ;
Dahi, Parastoo B. .
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01) :81-92
[22]   Stem Cell Transplantation in Childhood Non-Hodgkin's Lymphomas [J].
Okur, Fatma V. ;
Krance, Robert .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (04) :192-199
[23]   Reduced-intensity conditioning followed by allogeneic transplantation can produce clinical and molecular remissions in relapsed non-Hodgkin's lymphoma [J].
Corradini, P ;
Bregni, M ;
Tarella, C ;
Olivieri, A ;
Dodero, A ;
Farina, L ;
Zallio, F ;
Leoni, P ;
Ciceri, F ;
Devizzi, L ;
Benedetti, F ;
Pogliani, E ;
Rambaldi, A ;
Locasciulli, A ;
Falda, M ;
Santoro, A ;
Scime, R ;
Gianni, AM .
BONE MARROW TRANSPLANTATION, 2003, 31 :S57-S57
[24]   Stem Cell Transplantation in Childhood Non-Hodgkin’s Lymphomas [J].
Fatma V. Okur ;
Robert Krance .
Current Hematologic Malignancy Reports, 2010, 5 :192-199
[25]   Gemcitabine, Fludarabine; and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma [J].
Anderlini, Paolo ;
Saliba, Rima M. ;
Ledesma, Celina ;
Plair, Tamera ;
Alousi, Amin M. ;
Hosing, Chitra M. ;
Khouri, Issa F. ;
Nieto, Yago ;
Popat, Uday R. ;
Shpall, Elizabeth J. ;
Fanale, Michelle A. ;
Hagemeister, Frederick B. ;
Oki, Yasuhiro ;
Neelapu, Saatva ;
Romaguera, Jorge E. ;
Younes, Anas ;
Champlin, Richard E. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) :1333-1337
[26]   Allogeneic peripheral blood stem cell transplantation after reduced-intensity conditioning in refractory or relapsed Hodgkin lymphoma [J].
Alvarez, I ;
Sureda, A ;
Caballero, D ;
Urbano, A ;
Ribera, J ;
Canales, M ;
Hernández-Boluda, J ;
Arranz, R ;
Bernal, T ;
de la Serna, J ;
Diez, JL ;
Moraleda, J ;
Rubio-Félix, D ;
Sierra, J .
BONE MARROW TRANSPLANTATION, 2004, 33 :S13-S14
[27]   Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation For Relapsed/Refractory Hodgkin Lymphoma In The Brentuximab Vedotin Era [J].
Anderlini, Paolo ;
Saliba, Rima ;
Ledesma, Celina ;
Chancoco, Christina M. ;
Alexander, Tamera R. ;
Alousi, Amin M. ;
Hosing, Chitra ;
Khouri, Issa F. ;
Nieto, Yago ;
Popat, Uday R. ;
Shpall, Elizabeth J. ;
Fanale, Michelle A. ;
Oki, Yasuhiro ;
Romaguera, Jorge E. ;
Neelapu, Sattva S. ;
Younes, Anas ;
Champlin, Richard E. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) :S72-S72
[28]   Feasibility of allogeneic hematopoietic stem cell transplantation (HSCT) with a reduced-intensity (RI) conditioning regimen for non-Hodgkin's lymphoma (NHL). [J].
Kusumi, E ;
Tanimoto, TE ;
Kami, M ;
Hamaki, T ;
Yuji, K ;
Ueyama, J ;
Miyakoshi, S ;
Morinaga, S ;
Kanda, Y ;
Makimoto, A ;
Kataoka, I ;
Kim, SW ;
Ohnishi, M ;
Nakai, K ;
Tobinai, K ;
Tanosaki, R ;
Mineishi, S ;
Takaue, Y ;
Mutou, Y .
BLOOD, 2001, 98 (11) :377B-377B
[29]   Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma [J].
Wulf, GG ;
Hasenkamp, J ;
Jung, W ;
Chapuy, B ;
Truemper, L ;
Glass, B .
BONE MARROW TRANSPLANTATION, 2005, 36 (03) :271-273
[30]   Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma [J].
G G Wulf ;
J Hasenkamp ;
W Jung ;
B Chapuy ;
L Truemper ;
B Glass .
Bone Marrow Transplantation, 2005, 36 :271-273
12345